The University of Toronto is developing a platform that enables swapping of various sensing technologies that could measure different analytes in a range of applications.
Research groups and companies are developing and applying tools to enrich for and capture CTCs to diagnose tumors early and monitor patients during treatment.
In a recent study in Blood, the researchers showed that a higher allelic burden after transplantation was associated with higher risk of relapse and mortality.
